Product Information：
- Product name: Regorafenibis 40mg
- Manufacturer / brand: Laos Alliance
- Active ingredient: Regorafenibis
- Current strength:40mg
- SKU: 09-L-1386
- Site category: colorectal cancer,
Active Ingredient and Reference Data
Regorafenibis the active ingredient used for this product page. Public prescribing information for Regorafenib was used for the medical reference sections. Medical details are provided for reference and must be interpreted by a qualified healthcare professional.
Mechanism of Action
Regorafenib (Stivarga) is an oral multi-kinase inhibitor that simultaneously blocks VEGFR1/2/3, TIE2, PDGFR, FGFR, KIT, RET, and RAF/BRAF pathways, suppressing tumor angiogenesis, proliferation, and metastasis in previously treated mCRC, GIST, and HCC.
Storage and Purchase Notes
Store according to the package or pharmacist instructions and keep out of reach of children. Before ordering, confirm product name, strength, quantity, price, shipping details, and payment method. After receipt, check packaging, batch number, expiration date, and storage conditions.
Reviews
There are no reviews yet.